|
Age (year) [Mean (SD)]
|
35.45 (8.08)
|
|
Disease Duration [Mean (SD)]
|
7.63 (5.56)
|
|
Age of onset of disease [Mean (SD)]
|
26.85(7.81)
|
|
Sex [n (%)]
|
|
Female
|
474 (78.7)
|
|
Male
|
128 (21.3)
|
|
Marital status [n (%)]
|
|
Single
|
149 (24.8)
|
|
Married
|
415 (68.9)
|
|
Divorced and widowed
|
38 (6.3)
|
|
Education level [n (%)]
|
|
Secondary school or below
|
145 (24)
|
|
high school
|
214 (35.5)
|
|
University
|
244 (40.5)
|
|
Job status [n (%)]
|
|
Employed
|
128 (21.2)
|
|
Unemployed
|
52 (8.6)
|
|
housewife
|
378 (62.7)
|
|
Retired and disabled
|
45 (7.5)
|
|
Current comorbid conditions [n (%)]
|
|
Diabetes
|
7 (1.2)
|
|
Arthritis
|
8 (1.3)
|
|
Hypertension
|
17 (2.8)
|
|
Heart disease
|
5 (0.8)
|
|
Thyroid disorders
|
40 (6.6)
|
|
Migraine
|
37 (6.1)
|
|
Asthma
|
8 (1.3)
|
|
Inflammatory bowel disease
|
9 (1.5)
|
|
kidney disease
|
14 (2.3)
|
|
Liver disease
|
4 (0.7)
|
|
infectious disorders
|
2 (0.3)
|
|
Skin disorders
|
2 (0.3)
|
|
Epilepsy
|
11 (1.8)
|
|
Other disorders
|
64 (10.6)
|
|
None
|
375 (62.1)
|
|
EDSS Score [Mean (SD)]
|
2.45 (2.11)
|
|
EDSS Class [n (%)]
|
|
Mild (1–3)
|
432 (71.6)
|
|
Moderate (3.5–6.5)
|
151 (25)
|
|
Severe (≥ 7)
|
20 (3.4)
|
|
Course disease [n (%)]
|
|
Relapsing remitting
|
459 (76.1)
|
|
Primary progressive
|
19 (3.2)
|
|
Secondary progressive
|
97 (16.1)
|
|
CIS
|
28 (4.6)
|
|
MS medication [n (%)]
|
|
Interferon beta
|
203 (33.7)
|
|
Glatiramer acetate
|
47 (7.8)
|
|
Fingolimod
|
114 (18.9)
|
|
Natalizumab injection
|
41 (6.8)
|
|
Azathioprine
|
20 (3.3)
|
|
Ritoximab injection
|
97 (16.1)
|
|
Mitoxantrone
|
1 (0.2)
|
|
Dimethilfumarat
|
13 (2.2)
|
|
Trifulonumaide
|
4 (0.7)
|
|
Mix (Azathioprine&Interferonbeta)
|
24 (4)
|
|
Cyclophosmaide
|
8 (1.3)
|
|
Metotruxat
|
3 (0.5)
|
|
None
|
28 (4.6)
|
|
Symptomatic treatment [n (%)]
|
|
Anti-depressant
|
119(19.8)
|
|
Anticonvulsants
|
111(18.4)
|
|
Anti-anxiety
|
40(6.6)
|
|
Antipsychotic
|
17(2.8)
|
|
Anticholinergic
|
103(17.1)
|
|
anti-spasticity
|
86(14.3)
|
|
Anti-fatigue
|
56(9.3)
|
|
Beta blocker
|
37(6.1)
|
|
Levothyroxine
|
26(4.3)
|
|
anti-Anemia
|
35(5.8)
|
|
Amantadine
|
15(2.5)
|
|
supplements
|
377(62.6)
|
|
Anti-lipid
|
8(1.3)
|
|
NSAID
|
10(1.7)
|
|
Alpha Adrenergic Inhibitor
|
16(2.7)
|
|
Anti-acid
|
39(6.5)
|
|
Modafinil
|
8(1.3)
|
